drugset / Trial / NCT02554552

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

NCT02554552 ↗

Phase 1/2 Withdrawn Yooyoung Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YY1201 for treatment of osteoarthritis of the knee.

Timeline

Start
2015-09
Primary completion
2016-10
Completion
2016-10

Outcome

Outcome not reported

Stopped (Enrollment): “This study has been withdrawn prior to enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject YY1201 Unknown 2 ml Other
Subject YY1201 Unknown 3 ml Other

Indications